Neuroscience, Endocrinology, Internal medicine, Dopamine and Cannabinoid are his primary areas of study. Jussi Hirvonen combines subjects such as Carfentanil and Endogenous opioid with his study of Neuroscience. His Endocrinology research focuses on subjects like Receptor, which are linked to Major depressive disorder.
His Internal medicine research incorporates themes from White matter, Fractional anisotropy and Voxel. His primary area of study in Dopamine is in the field of Dopamine receptor D2. His research in Cannabinoid intersects with topics in Radioligand, Abstinence, Cannabinoid receptor, Pharmacology and Cannabis.
Jussi Hirvonen focuses on Internal medicine, Endocrinology, Neuroscience, Positron emission tomography and Receptor. He focuses mostly in the field of Internal medicine, narrowing it down to topics relating to Anxiety and, in certain cases, Mood and Depression. His Endocrinology research is multidisciplinary, relying on both Serotonin transporter and Carfentanil.
His research in Neuroscience focuses on subjects like Endogenous opioid, which are connected to Physical exercise and Opioidergic. His work is dedicated to discovering how Positron emission tomography, Artificial intelligence are connected with Neuroinformatics and other disciplines. Jussi Hirvonen has included themes like Psychosis and Addiction in his Dopamine study.
His primary areas of study are Internal medicine, Endocrinology, Amygdala, Carfentanil and Positron emission tomography. His studies in Internal medicine integrate themes in fields like Major depressive disorder, Depression and Anxiety. Jussi Hirvonen interconnects Endogenous opioid and Fatty acid in the investigation of issues within Endocrinology.
The study incorporates disciplines such as Brain activity and meditation and Functional magnetic resonance imaging in addition to Amygdala. His work in Carfentanil tackles topics such as μ-opioid receptor which are related to areas like Radioligand and -Naloxone. In his study, Raclopride and Binding potential is strongly linked to Pattern recognition, which falls under the umbrella field of Positron emission tomography.
Jussi Hirvonen mainly investigates Pattern recognition, Reference Region, Image processing, Neuroinformatics and Artificial intelligence. His Pattern recognition research includes themes of Raclopride and Control subjects. His Control subjects study frequently draws connections between adjacent fields such as Positron emission tomography.
His work deals with themes such as Body mass index, Obesity, Weight loss, Leptin and Beta oxidation, which intersect with Positron emission tomography. He combines topics linked to Binding potential with his work on Reference Region.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers
Hirvonen J;Goodwin Rs;Li Ct;Terry Ge.
Molecular Psychiatry (2012)
Is emotional contagion special? An fMRI study on neural systems for affective and cognitive empathy.
Lauri Nummenmaa;Jussi Hirvonen;Riitta Parkkola;Jari K. Hietanen.
NeuroImage (2008)
Dorsal striatum and its limbic connectivity mediate abnormal anticipatory reward processing in obesity.
Lauri Nummenmaa;Jussi Hirvonen;Jarna C. Hannukainen;Heidi Immonen.
PLOS ONE (2012)
Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia
Jussi Hirvonen;Theo G. M. van Erp;Jukka Huttunen;Sargo Aalto.
Archives of General Psychiatry (2005)
Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635.
Jussi Hirvonen;Hasse Karlsson;Hasse Karlsson;Jaana Kajander;Antti Lepola.
The International Journal of Neuropsychopharmacology (2008)
Increased Brain Fatty Acid Uptake in Metabolic Syndrome
Anna Karmi;Patricia Iozzo;Antti Viljanen;Jussi Hirvonen.
Diabetes (2010)
Social Laughter Triggers Endogenous Opioid Release in Humans
Sandra Manninen;Lauri Tuominen;Robin I. Dunbar;Tomi Karjalainen.
The Journal of Neuroscience (2017)
Obesity Is Associated with Decreased μ-Opioid But Unaltered Dopamine D2 Receptor Availability in the Brain
Henry K. Karlsson;Lauri Tuominen;Jetro J. Tuulari;Jussi Hirvonen.
The Journal of Neuroscience (2015)
Impact of Prolonged Cannabinoid Excretion in Chronic Daily Cannabis Smokers' Blood on Per Se Drugged Driving Laws
Mateus M. Bergamaschi;Erin L. Karschner;Robert S. Goodwin;Karl B. Scheidweiler.
Clinical Chemistry (2013)
Social touch modulates endogenous μ-opioid system activity in humans.
Lauri Nummenmaa;Lauri Tuominen;Robin Dunbar;Jussi Hirvonen.
NeuroImage (2016)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Turku University Hospital
Turku University Hospital
Turku University Hospital
Odense University Hospital
National Institutes of Health
National Institutes of Health
Turku University Hospital
Turku University Hospital
National Institutes of Health
National Institute on Drug Abuse
University of Zurich
University of Surrey
Brookhaven National Laboratory
Kyoto Pharmaceutical University
Chinese Academy of Sciences
University of Cambridge
Sungkyunkwan University
Universidade Federal de Viçosa
Indian Agricultural Research Institute
University of Paris-Saclay
University of Oxford
New York State Office for People With Developmental Disabilities
Joint Institute for Nuclear Research
Aristotle University of Thessaloniki
University of Otago
University of California, Irvine